We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Rothschild Foundation Donates USD 4.2 Million to Hebrew University for Coronavirus Research

By HospiMedica International staff writers
Posted on 14 Apr 2020
The Edmond de Rothschild Foundation (Tel Aviv, Israel) has donated USD 4.2 million to the Hebrew University of Jerusalem (Jerusalem, Israel) for funding its coronavirus research.

The Edmond de Rothschild Foundation is a philanthropic organization founded in Israel by the Rothschild family. More...
It operates within the framework of the international network of the Edmond de Rothschild Foundations around the world and continues the path of the Rothschild family’s philanthropic heritage for more than 130 years. The Foundation initiates dozens of innovative projects throughout Israel aimed at reducing social gaps and fostering young leadership. The Hebrew University is Israel's leading academic and research institution, serving 23,000 students from 80 countries. Founded in 1918 by visionaries including Albert Einstein and Sigmund Freud, HU is ranked among the world's 100 leading universities. To date, Hebrew University faculty and alumni have won eight Nobel Prizes, one Fields Medal and one Abel Prize.

The Hebrew University currently has 60 research teams who are working to find a vaccine, produce faster and cheaper testing methods, and develop targeted treatments for those afflicted by COVID-19. The donation will be used to fund their efforts to fight the coronavirus and control the COVID-19 pandemic.

“Since the outbreak of the pandemic, many researchers and laboratories at the Hebrew University have been working tirelessly to develop a scientific solution to the corona challenge. Several of these efforts are already close to market,” said Professor Asher Cohen, Hebrew University President

“We see science as a key tool for enhancing human capabilities, and it is symbolic that Israel, with its world-leading academic institutions and medical centers, would lead also on this front. The Rothschild family stands beside Israel and I am sure that together, we will overcome this crisis,” said Baroness Ariane de Rothschild.

“The Edmond de Rothschild Foundation’s generous donation will shorten the timeline for much needed corona diagnostic kits and treatments. I would like to personally thank all the researchers, lab assistants and students who have mobilized 24/7 to wipe out the virus,” said Professor Reem Sari, Hebrew University Vice President for Research and Development

“My deepest thanks to the nanotechnology researchers at Hebrew University. They’ve been working around the clock to find diverse solutions for this global threat, efforts that will ensure a swift return to our pre-corona lives,” said Professor Uriel Levy, Director of Hebrew University’s Center for Nanoscience and Nanotechnology.

Related Links:
The Edmond de Rothschild Foundation
The Hebrew University of Jerusalem




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.